Karyopharm Therapeutics, Inc. (KPTI)

10.09 +0.02 (+0.20%) USD  |  NASDAQ  |  Feb 25, 16:00
10.10 +0.01 (+0.10%) After-Hours: 20:00
More

Karyopharm Therapeutics Excess Tax Benefit from Stock Compensation (Quarterly)

Excess Tax Benefit from Stock Compensation (Quarterly) Chart

View Excess Tax Benefit from Stock Compensation (Quarterly) for KPTI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Excess Tax Benefit from Stock Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years

View Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks

View Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. --
Baxter International, Inc. --
Bruker Corp. --
Catalyst Pharmaceuticals, Inc. --
Agios Pharmaceuticals, Inc. --